Head-to-head comparison of tau PET tracers [18F]PI-2620 and [18F]RO948 in non-demented individuals with brain amyloid deposition: the TAU-PET FACEHBI cohort

被引:3
作者
Tonietto, Matteo [1 ]
Sotolongo-Grau, Oscar [2 ]
Roe-Vellve, Nuria [3 ]
Bullich, Santiago [3 ]
Tartari, Juan Pablo [2 ]
Sanabria, Angela [2 ,4 ]
Garcia-Sanchez, Ainhoa [2 ]
Borroni, Edilio [1 ]
Galli, Christopher [1 ]
Perez-Martinez, Esther [3 ]
Castell-Conesa, Joan [5 ]
Roca, Isabel [5 ]
Tarraga, Lluis [2 ,4 ]
Ruiz, Agustin [2 ,4 ]
Stephens, Andrew W. [3 ]
Boada, Merce [2 ,4 ]
Klein, Gregory [1 ]
Marquie, Marta [2 ,4 ]
机构
[1] F Hoffmann La Roche Ltd, Roche Innovat Ctr Basel, Roche Pharm Res & Early Dev Neurosci & Rare Dis, Basel, Switzerland
[2] Univ Int Catalunya, Ace Alzheimer Ctr Barcelona, Barcelona, Spain
[3] Life Mol Imaging GmbH, Berlin, Germany
[4] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Neurodegenerat, CIBERNED, Madrid, Spain
[5] SIMM Imagen Med, Barcelona, Spain
关键词
Tau; Positron emission tomography; 18F]PI-2620; 18F]RO948; FACEHBI; Subjective cognitive decline; Mild cognitive impairment; Alzheimer; BIOMARKERS; RISK;
D O I
10.1186/s13195-024-01622-5
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BackgroundSecond-generation tau tracers for positron emission tomography (PET) show high affinity for paired helical filaments tau deposits characteristic of Alzheimer<acute accent>s disease and low off-target binding. Differences in their chemical structure though may lead to variations in their regional tau uptake and off-target signal. In this work, we aimed to compare the in-vivo uptake of tau tracers [18F]PI-2620 and [18F]RO948 in the early stages of the AD continuum.MethodsData from the TAU-PET FACEHBI clinical trial (EUDRA-CT 2021-000473-83) were analyzed. All participants were non-demented and underwent tau imaging with [18F]PI-2620 and [18F]RO948 PET within 3 months, amyloid imaging with [18F]Florbetaben and brain magnetic resonance imaging. Tau PET standardized uptake values ratios (SUVR) were calculated in Braak and typical off-target regions using the inferior cerebellar cortex as a reference region.ResultsThe cohort consisted of 18 individuals with subjective cognitive decline (n = 13) and mild cognitive impairment (n = 5), with centiloid values ranging from 17 to 159. Both tau tracers showed similar tau pathology distribution but presented a distinct off-target signal pattern on visual read. SUVR measurements for [18F]PI-2620 and [18F]RO948 were highly correlated in all Braak regions (R2 range [0.65-0.80]). Regarding off-target signal, [18F]PI-2620 had higher SUVRs in vascular structures, and [18F]RO948 had higher SUVRs in the skull/meninges.ConclusionsIn a cohort of individuals at early stages of the AD continuum, tau PET tracers [18F]PI-2620 and [18F]RO948 showed similar in-vivo uptake in all Braak regions and distinct off-target signal. These preliminary results support the development of standardized quantification scales for tau deposition that are tracer-independent.Trial registrationAEMPS EudraCT 2021-000473-83. Registered 30 December 2021.
引用
收藏
页数:13
相关论文
共 52 条
[41]   Subtle executive deficits are associated with higher brain amyloid burden and lower cortical volume in subjective cognitive decline: the FACEHBI cohort [J].
Perez-Cordon, Alba ;
Monte-Rubio, Gemma ;
Sanabria, Angela ;
Rodriguez-Gomez, Octavio ;
Valero, Sergi ;
Abdelnour, Carla ;
Marquie, Marta ;
Espinosa, Ana ;
Ortega, Gemma ;
Hernandez, Isabel ;
Rosende-Roca, Maitee ;
Vargas, Liliana ;
Mauleon, Ana ;
Gil, Silvia ;
Tartari, Juan Pablo ;
Lomena, Francisco ;
Campos, Francisco ;
Vivas, Assumpta ;
Gomez-Chiari, Marta ;
Benaque, Alba ;
Ruiz, Agustin ;
Tarraga, Luis ;
Boada, Merce ;
Alegret, Montserrat .
SCIENTIFIC REPORTS, 2020, 10 (01)
[42]   FACEHBI: A Prospective Study of Risk Factors, Biomarkers and Cognition in a Cohort of Individuals with Subjective Cognitive Decline. Study Rationale and Research Protocols [J].
Rodriguez-Gomez, O. ;
Sanabria, A. ;
Perez-Cordon, A. ;
Sanchez-Ruiz, D. ;
Abdelnour, C. ;
Valero, S. ;
Hernandez, I ;
Rosende-Roca, M. ;
Mauleon, A. ;
Vargas, L. ;
Alegret, M. ;
Espinosa, A. ;
Ortega, G. ;
Guitart, M. ;
Gailhajanet, A. ;
Sotolongo-Grau, O. ;
Moreno-Grau, S. ;
Ruiz, S. ;
Tarragona, M. ;
Serra, J. ;
Martin, E. ;
Peleja, E. ;
Lomena, F. ;
Campos, F. ;
Vivas, A. ;
Gomez-Chiari, M. ;
Tejero, M. A. ;
Gimenez, J. ;
Pesini, P. ;
Sarasa, M. ;
Martinez, G. ;
Ruiz, A. ;
Tarraga, L. ;
Boada, M. .
JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE, 2017, 4 (02) :100-108
[43]   18F-Florbetaben PET beta-amyloid binding expressed in Centiloids [J].
Rowe, Christopher C. ;
Dore, Vincent ;
Jones, Gareth ;
Baxendale, David ;
Mulligan, Rachel S. ;
Bullich, Santiago ;
Stephens, Andrew W. ;
De Santi, Susan ;
Masters, Colin L. ;
Dinkelborg, Ludger ;
Villemagne, Victor L. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (12) :2053-2059
[44]   The Spanish version of Face-Name Associative Memory Exam (S-FNAME) performance is related to amyloid burden in Subjective Cognitive Decline [J].
Sanabria, Angela ;
Alegret, Montserrat ;
Rodriguez-Gomez, Octavio ;
Valero, Sergi ;
Sotolongo-Grau, Oscar ;
Monte-Rubio, Gemma ;
Abdelnour, Carla ;
Espinosa, Ana ;
Ortega, Gemma ;
Perez-Cordon, Alba ;
Gailhajanet, Anna ;
Hernandez, Isabel ;
Rosende-Roca, Maitee ;
Vargas, Liliana ;
Mauleon, Ana ;
Sanchez, Domingo ;
Martin, Elvira ;
Rentz, Dorene M. ;
Lomena, Francisco ;
Ruiz, Agustin ;
Tarraga, Lluis ;
Boada, Merce .
SCIENTIFIC REPORTS, 2018, 8
[45]   PET Imaging of Tau Deposition in the Aging Human Brain [J].
Schoell, Michael ;
Lockhart, Samuel N. ;
Schonhaut, Daniel R. ;
O'Neil, James P. ;
Janabi, Mustafa ;
Ossenkoppele, Rik ;
Baker, Suzanne L. ;
Vogel, Jacob W. ;
Faria, Jamie ;
Schwimmer, Henry D. ;
Rabinovici, Gil D. ;
Jagust, William J. .
NEURON, 2016, 89 (05) :971-982
[46]   Sex differences in off-target binding using tau positron emission tomography [J].
Smith, Ruben ;
Strandberg, Olof ;
Leuzy, Antoine ;
Betthauser, Tobey J. ;
Johnson, Sterling C. ;
Pereira, Joana B. ;
Hansson, Oskar .
NEUROIMAGE-CLINICAL, 2021, 31
[47]   Head-to-head comparison of tau positron emission tomography tracers [18F]flortaucipir and [18F]RO948 [J].
Smith, Ruben ;
Scholl, Michael ;
Leuzy, Antoine ;
Jogi, Jonas ;
Ohlsson, Tomas ;
Strandberg, Olof ;
Hansson, Oskar .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (02) :342-354
[48]   International consensus on the use of tau PET imaging agent 18F-flortaucipir in Alzheimer's disease [J].
Tian, Mei ;
Civelek, A. Cahid ;
Carrio, Ignasi ;
Watanabe, Yasuyoshi ;
Kang, Keon Wook ;
Murakami, Koji ;
Garibotto, Valentina ;
Prior, John O. ;
Barthel, Henryk ;
Zhou, Rui ;
Hou, Haifeng ;
Dou, Xiaofeng ;
Jin, Chentao ;
Zuo, Chuantao ;
Zhang, Hong .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (03) :895-904
[49]   Tau imaging: early progress and future directions [J].
Villemagne, Victor L. ;
Fodero-Tavoletti, Michelle T. ;
Masters, Colin L. ;
Rowe, Christopher C. .
LANCET NEUROLOGY, 2015, 14 (01) :114-124
[50]   Automatic segmentation of the choroid plexuses: Method and validation in controls and patients with multiple sclerosis [J].
Yazdan-Panah, Arya ;
Schmidt-Mengin, Marius ;
Ricigliano, Vito A. G. ;
Soulier, Theodore ;
Stankoff, Bruno ;
Colliot, Olivier .
NEUROIMAGE-CLINICAL, 2023, 38